PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32132025-0	2020	Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness.	Sorafenib	43-52	androgen receptor	Homo sapiens	0-17	
32132025-4	2020	This study investigated sorafenib effect on AR in experimental models of HCC.	Sorafenib	24-33	androgen receptor	Homo sapiens	44-46	
32132025-18	2020	CONCLUSION: AR+/EpCAM+ may be a marker of responsiveness to sorafenib for patients with HCC.	Sorafenib	60-69	androgen receptor	Homo sapiens	12-14